AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,173 | 1,583 | 1,101 | 813 | 29,448 |
| Gross Profit | 1,173 | 1,583 | 1,101 | 813 | 29,448 |
| Operating Expenses | 21,373 | 25,085 | 22,649 | 22,592 | 21,049 |
| Operating Income | -20,199 | -23,502 | -21,547 | -21,779 | 8,399 |
| Interest Expense | 58 | 61 | 60 | 34 | 38 |
| Other Income | 442 | -2,123 | 439 | 3,206 | -2,003 |
| Pre-tax Income | -19,815 | -25,685 | -21,168 | -18,607 | 6,359 |
| Net Income Continuous | -19,815 | -25,685 | -21,168 | -18,610 | 6,359 |
| Net Income | $-19,815 | $-25,685 | $-21,168 | $-18,610 | $6,359 |
| EPS Basic Total Ops | -0.20 | -0.25 | -0.21 | -0.19 | 0.07 |
| EPS Basic Continuous Ops | -0.20 | -0.26 | -0.21 | -0.19 | 0.06 |
| EPS Diluted Total Ops | -0.20 | -0.25 | -0.21 | -0.18 | 0.06 |
| EPS Diluted Continuous Ops | -0.20 | -0.26 | -0.21 | -0.18 | 0.06 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.25 | -0.21 | -0.18 | 0.06 |
| EBITDA(a) | $-19,387 | $-22,686 | $-20,866 | $-21,210 | $9,066 |